Fundraising FoxPurple Arch Ventures — Full Portfolio
3 tracked investments · listed companies and verified rows first
Exicure is a publicly-traded holding company that previously developed nucleic acid therapies and has since divested its historical biotechnology assets; it is now pursuing growth through acquisitions and partnerships, including a recent investment in GPCR Therapeutics USA, which is developing small molecule therapies for blood cancers and multiple myeloma.
BiotechSkokie, US
Chad A. Mirkin(Director)C. Shad Thaxton(Director)David A. Giljohann(Chief Executive Officer)inDavid S. Snyder(Chief Financial Officer)inPercy Van Crocker, Jr.(Vice President, Commercial Development)
BoardJay Venkatesan(Director)
Co-investorsAbbVieInnovation EndeavorsRockPort Capital Partners
BlockFi was a cryptocurrency financial services company; its site now serves only as a wind-down and client remediation portal covering bankruptcy distributions, identity verification, and phishing warnings.
Crypto & Web3FintechNew York, US
Flori Marquez(Executive Officer)Zachary Lee Prince(Executive Officer, Director)Christopher Richard Shaffer(Executive Officer)
BoardKavita Gupta(Director)
Co-investorsAlumni VenturesBlockchain CoinvestorsCastor VenturesGalaxy VenturesSprint VcConsensys Ventures+6 more
Chicago, US
Rohit Pasam(Executive Officer, Director, Promoter)
Co-investorsAlumni VenturesHyde Park AngelsIllinois VenturesLOUD CapitalVCapital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.